Equities researchers at William Blair increased their FY2026 EPS estimates for argenx in a research note issued on Friday, ...

Analysts at William Blair issued their Q1 2025 earnings per share estimates for First Solar in a note issued to investors on ...

William Blair reiterated their outperform rating on shares of Vital Farms (NASDAQ:VITL – Free Report) in a report published on Friday morning,RTT News reports. William Blair also issued estimates for ...

Investment analysts at William Blair boosted their Q3 2026 earnings per share (EPS) estimates for shares of Salesforce in a ...

William Blair issued their Q1 2026 earnings estimates for shares of Verve Therapeutics in a report issued on Thursday, ...

Already billed as a potential blockbuster, Amgen and AstraZeneca’s Tezspire has turned in strong clinical data in chronic ...

William Blair restated their outperform rating on shares of Xenon Pharmaceuticals (NASDAQ:XENE – Free Report) in a report ...

Analysts at William Blair issued their Q1 2026 earnings estimates for shares of Rocket Pharmaceuticals in a note issued to ...

William Blair started coverage on shares of Structure Therapeutics (NASDAQ:GPCR – Free Report) in a research note published on Friday, Marketbeat Ratings reports. The brokerage issued an outperform ...

William Blair issued their Q1 2026 earnings per share estimates for shares of Workday in a report released on Wednesday, ...

William Blair restated their outperform rating on shares of Alignment Healthcare (NASDAQ:ALHC – Free Report) in a research report released on Friday,RTT News reports. Several other equities research ...

Equities research analysts at William Blair issued their Q3 2025 earnings per share estimates for U.S. Physical Therapy in a research report issued on Thursday, February 27th. William Blair analyst J.